company background image
BNN logo

BRAIN Biotech XTRA:BNN Stock Report

Last Price

€3.92

Market Cap

€85.6m

7D

1.0%

1Y

-43.2%

Updated

03 Mar, 2024

Data

Company Financials +

BNN Stock Overview

BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom.

BNN fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health3/6
Dividends0/6

BRAIN Biotech AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BRAIN Biotech
Historical stock prices
Current Share Price€3.92
52 Week High€7.14
52 Week Low€3.21
Beta1.3
1 Month Change11.68%
3 Month Change11.05%
1 Year Change-43.19%
3 Year Change-54.84%
5 Year Change-62.95%
Change since IPO-56.91%

Recent News & Updates

Is BRAIN Biotech (ETR:BNN) A Risky Investment?

Feb 16
Is BRAIN Biotech (ETR:BNN) A Risky Investment?

Recent updates

Is BRAIN Biotech (ETR:BNN) A Risky Investment?

Feb 16
Is BRAIN Biotech (ETR:BNN) A Risky Investment?

Here's Why BRAIN Biotech (ETR:BNN) Can Afford Some Debt

Sep 13
Here's Why BRAIN Biotech (ETR:BNN) Can Afford Some Debt

Here's What B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shareholder Ownership Structure Looks Like

Mar 21
Here's What B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shareholder Ownership Structure Looks Like

Is B.R.A.I.N. Biotechnology Research and Information Network (ETR:BNN) Weighed On By Its Debt Load?

Feb 14
Is B.R.A.I.N. Biotechnology Research and Information Network (ETR:BNN) Weighed On By Its Debt Load?

When Will B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) Breakeven?

Jan 18
When Will B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) Breakeven?

How Much Did B.R.A.I.N. Biotechnology Research and Information Network's(ETR:BNN) Shareholders Earn From Share Price Movements Over The Last Three Years?

Dec 31
How Much Did B.R.A.I.N. Biotechnology Research and Information Network's(ETR:BNN) Shareholders Earn From Share Price Movements Over The Last Three Years?

Are Institutions Heavily Invested In B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shares?

Dec 10
Are Institutions Heavily Invested In B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shares?

Should You Investigate B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) At €7.30?

Nov 17
Should You Investigate B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) At €7.30?

Shareholder Returns

BNNDE ChemicalsDE Market
7D1.0%1.6%1.2%
1Y-43.2%-7.5%1.0%

Return vs Industry: BNN underperformed the German Chemicals industry which returned -7.5% over the past year.

Return vs Market: BNN underperformed the German Market which returned 1% over the past year.

Price Volatility

Is BNN's price volatile compared to industry and market?
BNN volatility
BNN Average Weekly Movement5.8%
Chemicals Industry Average Movement4.3%
Market Average Movement4.7%
10% most volatile stocks in DE Market10.0%
10% least volatile stocks in DE Market2.4%

Stable Share Price: BNN has not had significant price volatility in the past 3 months.

Volatility Over Time: BNN's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993318Aryan Moelkerhttps://www.brain-biotech.com

BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates in three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals.

BRAIN Biotech AG Fundamentals Summary

How do BRAIN Biotech's earnings and revenue compare to its market cap?
BNN fundamental statistics
Market cap€85.64m
Earnings (TTM)-€8.39m
Revenue (TTM)€55.16m

1.6x

P/S Ratio

-10.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BNN income statement (TTM)
Revenue€55.16m
Cost of Revenue€24.82m
Gross Profit€30.33m
Other Expenses€38.73m
Earnings-€8.39m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 28, 2024

Earnings per share (EPS)-0.38
Gross Margin55.00%
Net Profit Margin-15.22%
Debt/Equity Ratio0%

How did BNN perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.